Polyfarmasi
Hubbard RE, O'Mahony MS, Woodhouse KW. Medication prescribing in frail older people. . Eur J Clin Pharmacol. 2013;69(3):319-26.
Bhavik M. Shah, Emily R. Hajjar. Polypharmacy, Adverse Drug Reactions, and Geriatric Syndromes. Clinics in Geriatric Medicine. 2012; 28(2):173–186
Tamura BK, Bell CL, Inaba M, Masaki KH. Outcomes of Polypharmacy in Nursing Home Residents Clinics in Geriatric Medicine. 2012; 28(2):217–236
Diabetes
Levetan C. Oral antidiabetic agents in type 2 diabetes. Curr Med Res Opin. 2007;23(4):945-52.
Fravel MA, et al. Special considerations for treatment of type 2 diabetes mellitus in the elderly. Am J Health Syst Pharm. 2011;68(6):500-9.
Hjerte/kar
Kardiovaskul?r sykdomsrisiko
Berge E, Dahl T. Hjertesykdom og hjerneslag. Tidsskr Nor L?geforen 2007;127:897-9.
Russell D, et al. Prim?rprofylakse mot hjerneslag. Tidsskr Nor L?geforen 2007;127:754-8.
Hollan I, et al. Revmatoid artritt – en risikofaktor for iskemisk hjertesykdom. Tidsskr Nor L?geforen 2005;125:3259-62.
Gerdts E, et al. Hypertensjon og hjertesykdom. Tidsskr Nor L?geforen 2004;124:802-5
Selmer R, et al. Modell for estimering av kardiovaskul?r risiko i Norge. Tidsskr Nor Legeforen. 2008;128(3):286-90.
Antitrombotisk behandling
Ghanima W, Atar D, Sandset PM New oral anticoagulants--a review. Tidsskr Nor Laegeforen. 2013;133(18):1940-5.
Aamodt AH, et al. Atrial fibrillation and stroke. Tidsskr Nor Laegeforen. 2013;133(14):1453-7.
Statinbehandling
Bogsrud MP, Reikvam ?, Retterst?l K. Behandling med statiner Tidsskr Nor Legeforen 2013; 133:1316?–?9
Ong HT. The statin studies: from targeting hypercholesterolaemia to targeting the high-risk patient. QJM. 2005;98(8):599-614.
Palaniswamy C, et al. Mechanisms underlying pleiotropic effects of statins. Am J Ther. 2010;17(1):75-8.
Venero CV, Thompson PD. Managing statin myopathy. Endocrinol Metab Clin North Am. 2009;38(1):121-36.
Hypertensjonsbehandling
ESH/ESC Task Force for the Management of Arterial Hypertension. 2013 Practice guidelines for the management of arterial hypertension of the European Society of Hypertension (ESH) and the European Society of Cardiology (ESC): ESH/ESC Task Force for the Management of Arterial Hypertension. J Hypertens. 2013;31(10):1925-38.
Vinkenes K, Kjeldsen SE. Hypertensjon hos friske over 80 ?r b?r behandles. Tidsskr Nor Laegeforen. 2013;133(17):1804-5.
Sch?fer HH, et al. Recommendations for the treatment of hypertension in the elderly and very elderly--a scotoma within international guidelines. Swiss Med Wkly. 2012;142:w13574
Hjertesviktbehandling
McMurray JJV, et al. ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2012. European Heart Journal 2012; 33: 1787-1847. Erratum in: Eur Heart J. 2013;34(2):158.
McDonagh TA. Challenges in advanced chronic heart failure: drug therapy. Future Cardiol. 2008;4(5):517-25.
Tousoulis D, et al. Role of depression in heart failure--choosing the right antidepressive treatment. Int J Cardiol. 2010;140(1):12-8.
Revmatisme
Scrivo R, et al. The immunology of rheumatoid arthritis. Ann N Y Acad Sci. 2007;1108:312-22.
Sizova L. Approaches to the treatment of early rheumatoid arthritis with disease-modifying antirheumatic drugs. Br J Clin Pharmacol. 2008;66(2):173-8.
Flugsrud GB, et al. Artrose. Tidsskr Nor Laegeforen. 2010;130(21):2136-40.
Jordan KM. Up-to-date management of gout. Curr Opin Rheumatol. 2012;24(2):145-51.
Uhlig T. Urinsyregikt og hyperurikemi – skal begge deler behandles? Tidsskr Nor Laegeforen. 2003;123(20):2878-80.
Stamp LK, Jordan S. The challenges of gout management in the elderly. Drugs Aging. 2011;28(8):591-603.
Schnitzer TJ. Update on guidelines for the treatment of chronic musculoskeletal pain. Clin Rheumatol. 2006;25 Suppl 1:S22-9.
Smerte
van Ojik AL, Jansen PA, Brouwers JR, van Roon EN. Treatment of chronic pain in older people: evidence-based choice of strong-acting opioids. Drugs Aging. 2012;29(8):615-25.
Pedersen L, Hansen AB, Svendsen K, Skurtveit S, Borchgrevink PC, Fredheim OMS. Analgetika med refusjon ved kroniske smerter. Tidsskr Nor Legeforen 2012;132:2489?–?93
G D Slap? GD, Schj?tt J. Medikamentell behandling av nevropatisk smerte. Tidsskr Nor Legeforen 2013;133:971?–?3
Psykiatri/s?vn
Khawam EA, et al. Side effects of antidepressants: an overview. Cleve Clin J Med. 2006;73(4):351-3, 356-61.
Liamis G, et al. A review of drug-induced hyponatremia. Am J Kidney Dis. 2008;52(1):144-53.
Castberg I. Seponeringssyndrom etter behandling med antidepressiver. Tidsskr Nor L?geforen 2004;124:2493-4.
Buscemi N, Vandermeer B, Friesen C et al. The efficacy and safety of drug treatments for chronic insomnia in adults: a meta-analysis of RCTs. J Gen Intern Med 2007;22:335?–?50.
Fetveit A, Bjorvatn B. S?vnforstyrrelser hos eldre. Tidsskr Nor Legeforen 2009;129: 2004?–?6.
Tannenbaum C, Martin P, Tamblyn R, Benedetti A, Ahmed S. Reduction of Inappropriate Benzodiazepine Prescriptions Among Older Adults Through Direct Patient Education: The EMPOWER Cluster Randomized Trial. JAMA Intern Med. 2014 Apr 14. doi: 10.1001/jamainternmed.2014.949.
Forstoppelse og diare
Tack J, et al. Diagnosis and treatment of chronic constipation--a European perspective. Neurogastroenterol Motil. 2011;23(8):697-710.
Lindberg G, et al. World Gastroenterology Organisation global guideline: Constipation--a global perspective. J Clin Gastroenterol. 2011;45(6):483-7.
Geriatri
Singh B, O'Brien JT. When should drug treatment be started for people with dementia? Maturitas. 2009;62(3):230-4.
Landmark K, Reikvam ?. Kolinesterasehemmere mot demens – nyttig i klinisk praksis? Tidsskr Nor Legeforen 2008;128:294-7.
Kristjansson S, Wyller T. Avslutning av forebyggende legemiddelbruk hos eldre. Tidsskr Nor Legeforen 2010;130:1726-8.
Kersten H, et al. Farmakoterapi i sykehjem.Tidsskr Nor Legeforen 2009;129:1732-5.
Neerland BE, Watne LO, Wyller TB. Delirium hos eldre pasienter.Tidsskr Nor Legeforen 2013;133:1596?–?600
Ranhoff A, Br?rs O. Legemidler som kan gi delirium hos eldre. Tidsskr Nor L?geforen 2005; 125:2366-7.
Cancelli I, et al. Drugs with anticholinergic properties: cognitive and neuropsychiatric side-effects in elderly patients. Neurol Sci.2009;30(2):87-92.
Hersch EC, Falzgraf S. Management of the behavioural and psychological symptoms of dementia. Clin Interv Aging. 2007;2(4):611-21.
Woolcott JC, et al. Meta-analysis of the impact of 9 medication classes on falls in elderly persons. Arch Intern Med. 2009;169(21):1952-60.
Hill KD, Wee R. Psychotropic drug-induced falls in older people: a review of interventions aimed at reducing the problem. Drugs Aging. 2012;29(1):15-30.
Husebo BS, et al. Efficacy of treating pain to reduce behavioural disturbances in residents of nursing homes with dementia: cluster randomised clinical trial. BMJ. 2011;343:d4065..
Osteoporose
Syversen U, Halse JI. Bisfosfonatbehandling av osteoporose og andre skjelettsykdommer. Tidsskr Nor Legeforen. 2011;131:244-7.
Mazziotti G, et al. Drug-induced osteoporosis: mechanisms and clinical implications. Am J Med. 2010;123(10):877-84.
Zapolski T, Wysokiński A. Safety of pharmacotherapy of osteoporosis in cardiology patients. Cardiol J. 2010;17(4):335-43.
Retningslinjer
- Diabetes – Forebygging, diagnostikk og behandling. Helsedirektoratet. 2011
- Hypertensjon - ESH / ESC Guidelines for the management of hypertension
- Hjerneslag - Nasjonale retningslinjer for behandling og rehabilitering ved hjerneslag. Helsedirektoratet, 2010.
- Veileder Warfarinbehandling i praksis - Tryggere antikoagulasjon. Den norske legeforening, 2010
- Atrial Fibrillation (Management of) 2010 and Focused Update (2012). European Society of Cardiology, 2012
- Forebygging - Nasjonale Retningslinjer for individuell prim?rforebygging av hjerte- og karsykdommer. Helsedirektoratet, 2009
- NSTEMI. European Society of Cardiology, 2011
- Offisielle metodebok-kapitler fra Norsk geriatrisk forening
- Nasjonale retningslinjer for diagnostisering og behandling av voksne med depresjon i prim?r- og spesialisthelsetjenesten. Helsedirektoratet, 2009